UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 268

Sortiert nach

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

The Lancet (British edition), 2017-06, Vol.389 (10088), p.2492-2502

2017

Volltextzugriff (PDF)

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Journal of hepatology, 2019-09, Vol.71 (3), p.543-552

2019

Volltextzugriff (PDF)

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

Hepatology (Baltimore, Md.), 2006-02, Vol.43 (2), p.209-220

2006

Volltextzugriff (PDF)

Value of quality of life analysis in liver cancer: A clinician’s perspective

World journal of hepatology, 2017-07, Vol.9 (20), p.867-883

2017

Volltextzugriff (PDF)

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Clinical gastroenterology and hepatology, 2016-06, Vol.14 (6), p.875-886.e6

2016

Volltextzugriff (PDF)

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

JNCI : Journal of the National Cancer Institute, 2019-12, Vol.111 (12), p.1298-1306

2019

Volltextzugriff (PDF)

Targeted therapy of hepatocellular carcinoma: Present and future

Journal of gastroenterology and hepatology, 2012-05, Vol.27 (5), p.862-872

2012

Volltextzugriff (PDF)

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

British journal of cancer, 2016-03, Vol.114 (7), p.744-750

2016

Volltextzugriff (PDF)

Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1660-1665

2010

Volltextzugriff (PDF)

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

Integrative cancer therapies, 2019-01, Vol.18, p.1534735419836501-1534735419836501

2019

Volltextzugriff (PDF)

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

Investigational new drugs, 2021-10, Vol.39 (5), p.1375-1382

2021

Volltextzugriff (PDF)

Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma

Future oncology (London, England), 2011-10, Vol.7 (10), p.1149-1167

2011

Volltextzugriff (PDF)

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Journal of clinical oncology, 2009-02, Vol.27 (4), p.605-611

2009

Volltextzugriff (PDF)

Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

Breast cancer research and treatment, 2019-10, Vol.177 (3), p.549-559

2019

Volltextzugriff (PDF)

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

British journal of cancer, 2017-02, Vol.116 (4), p.448-454

2017

Volltextzugriff (PDF)

Association of high adherence to vegetables and fruits dietary pattern with quality of life among Chinese women with early-stage breast cancer

Quality of life research, 2022-05, Vol.31 (5), p.1371-1384

2022

Volltextzugriff (PDF)

The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients

Breast cancer research and treatment, 2020-05, Vol.181 (1), p.167-180

2020

Volltextzugriff (PDF)

Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort

Breast cancer research and treatment, 2022-06, Vol.193 (3), p.649-658

2022

Volltextzugriff (PDF)

Longitudinal change of quality of life in the first five years of survival among disease-free Chinese breast cancer survivors

Quality of life research, 2021-06, Vol.30 (6), p.1583-1594

2021

Volltextzugriff (PDF)

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3361-3367

2012

Volltextzugriff (PDF)

High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma

Journal of clinical oncology, 2008-01, Vol.26 (2), p.177-182

2008

Volltextzugriff (PDF)

Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome

Cardiovascular and interventional radiology, 2022-02, Vol.45 (2), p.172-181

2022

Volltextzugriff (PDF)

Development of systemic therapy for hepatocellular carcinoma at 2013:Updates and insights

World journal of gastroenterology : WJG, 2014-03, Vol.20 (12), p.3135-3145

2014

Volltextzugriff (PDF)

Weight and waist-to-hip ratio change pattern during the first five years of survival: data from a longitudinal observational Chinese breast cancer cohort

BMC cancer, 2021-07, Vol.21 (1), p.1-839, Article 839

2021

Volltextzugriff (PDF)

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Journal of clinical oncology, 2009-01, Vol.27 (3), p.446-452

2009

Volltextzugriff (PDF)

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(189)
Life Sciences & Biomedicine
(183)
Humans
(168)
Female
(132)
Middle Aged
(113)
Oncology
(104)
Male
(97)
Adult
(89)
Aged
(83)
Biological And Medical Sciences
(69)
Medical Sciences
(66)
Tumors
(50)
Chemotherapy
(48)
Breast Cancer
(45)
Hepatocellular Carcinoma
(39)
Treatment Outcome
(37)
Carcinoma, Hepatocellular - Pathology
(34)
Liver Neoplasms - Pathology
(34)
Prognosis
(32)
Prospective Studies
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

Value of quality of life analysis in liver cancer: A clinician’s perspective

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

Targeted therapy of hepatocellular carcinoma: Present and future

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

Association of high adherence to vegetables and fruits dietary pattern with quality of life among Chinese women with early-stage breast cancer

The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients

Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort

Longitudinal change of quality of life in the first five years of survival among disease-free Chinese breast cancer survivors

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma

Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome

Development of systemic therapy for hepatocellular carcinoma at 2013:Updates and insights

Weight and waist-to-hip ratio change pattern during the first five years of survival: data from a longitudinal observational Chinese breast cancer cohort

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Suchergebnisse filtern